Literature DB >> 20147899

Inflammation and cancer: causes and consequences.

M M Moore1, W Chua, K A Charles, S J Clarke.   

Abstract

The link between chronic inflammation and increased risk of developing some cancers is well established. The molecular mechanisms that underlie this process (cause) as well as the chronic inflammation that accompanies cancer (consequence) continue to be elucidated. Cancer-associated inflammation has effects on the ability of cancers to metastasize, on the clinical manifestations of cancer, and on the ability of the patient to tolerate anticancer therapy. The identification of biomarkers of cancer-associated inflammation will assist in identifying patients at risk of its consequences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147899     DOI: 10.1038/clpt.2009.254

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  77 in total

1.  Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.

Authors:  Ulrike Haug; Elizabeth M Poole; Liren Xiao; Karen Curtin; David Duggan; Li Hsu; Karen W Makar; Ulrike Peters; Richard J Kulmacz; John D Potter; Lisel Koepl; Bette J Caan; Martha L Slattery; Cornelia M Ulrich
Journal:  Genes Chromosomes Cancer       Date:  2012-02-27       Impact factor: 5.006

2.  Prognostic value of 18F-fluorodeoxyglucose PET parameters and inflammation in patients with nasopharyngeal carcinoma.

Authors:  Liting Zhong; Chunming Li; Yunyan Ren; Dehua Wu
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

3.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

4.  Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.

Authors:  Young Wha Koh; Hee Jin Lee; Jin-Hee Ahn; Jong Won Lee; Gyungyub Gong
Journal:  Tumour Biol       Date:  2014-07-02

5.  Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

Authors:  Xiang Chen; JiaXi Yao; Li Liu; WenZhong Zheng; XiaoYi Hu; YanJun Zhu; Hang Wang; JianMing Guo
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

6.  Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai.

Authors:  Ilir Agalliu; Sadie Costello; Katie M Applebaum; Roberta M Ray; George Astrakianakis; Dao Li Gao; David B Thomas; Harvey Checkoway; Ellen A Eisen
Journal:  Cancer Causes Control       Date:  2011-07-06       Impact factor: 2.506

7.  Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer.

Authors:  Sonja Badovinac; Marta Korsic; Davorka Mursic; Miroslav Samarzija; Branka Cucevic; Mihovil Roglic; Marko Jakopovic
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

8.  Accurate use of neutrophil to lymphocyte ratio in predicting prognosis of papillary thyroid carcinoma.

Authors:  Erdim Sertoglu; Huseyin Kayadibi; Metin Uyanik
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

Review 9.  Carcinogenesis: the cancer cell-mast cell connection.

Authors:  Maria-Angeles Aller; Ana Arias; Jose-Ignacio Arias; Jaime Arias
Journal:  Inflamm Res       Date:  2018-11-20       Impact factor: 4.575

Review 10.  Diabetes and cancer: Associations, mechanisms, and implications for medical practice.

Authors:  Chun-Xiao Xu; Hong-Hong Zhu; Yi-Min Zhu
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.